Cystic Fibrosis Foundation 13D/13G Filings for BiomX Inc. (PHGE)

Cystic Fibrosis Foundation 13D and 13G filings for BiomX Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-03-04
5:34 pm
Sale		 2025-02-27 13G BiomX Inc.
PHGE		 Cystic Fibrosis Foundation 2,494,110
9.990%		 -1,600,448decrease
(-39.09%)		 Filing
2025-02-14
4:05 pm
Purchase		 2024-09-30 13G BiomX Inc.
PHGE		 Cystic Fibrosis Foundation 4,094,558
19.990%		 3,161,500increase
(+338.83%)		 Filing
2024-03-26
4:30 pm
Purchase		 2024-03-26 13G BiomX Inc.
PHGE		 Cystic Fibrosis Foundation 933,058
15.600%		 477,827increase
(+104.96%)		 Filing
2024-01-30
4:05 pm
Purchase		 2024-01-30 13G BiomX Inc.
PHGE		 Cystic Fibrosis Foundation 455,232
9.900%		 180,133increase
(+65.48%)		 Filing
2023-03-08
5:22 pm
Purchase		 2023-02-27 13G BiomX Inc.
PHGE		 Cystic Fibrosis Foundation 275,099
8.100%		 275,099increase
(New Position)		 Filing